lexipafant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Platelet-activating factor (PAF), also known as PAF-acether and AGEPC (acetyl-glyceryl-ether-phosphorylcholine), is a lipid…
BACKGROUND AND STUDY AIMS
Extrahepatic cholestasis is one of the main factors causing liver fibrosis. In this study, we aimed to…
Postoperative intra-abdominal adhesion formation is a major cl in ical problem. We aimed to examine the preventive effect of…
In recent years it has become evident that both the intrapancreatic events and, even more, the extrapancreatic manifestations of…
Two trials investigating the use of the platelet activating factor antagonist lexipafant have shown that treatment with the agent…
&The platelet-activating factor (PAF) antagonist lexipafant has a role in the treatment of acute pancreatitis, according to…